Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times

DOI10.17615/p0k8-y378MaRDI QIDQ2861966zbMATH OpenOpenAlexWikidataFDO

Authors Brent A. Johnson, Heather Ribaudo, Roy M. Gulick, Joseph J. jun. Eron

Publication date 13 November 2013

Published in Biometrics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.17615/p0k8-y378

zbMATH Keywords

causal inferencepropensity scoreobservational datainformative censoring

Mathematics Subject Classification ID

Estimation in survival analysis and censored data (62N02) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)

Recommendations

• Evaluating the effect of early versus late ARV regimen change if failure on an initial regimen: results from the AIDS clinical trials group study A5095
• Segmental modeling of changing immunologic response for CD4 data with skewness, missingness and dropout
• Viral suppression in HIV studies: combining times to suppression and rebound
• Missing Time-Dependent Covariates in Human Immunodeficiency Virus Dynamic Models
• Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients

Cites work

• scientific article; zbMATH DE number 3385132 (Why is no real title available?)
• Estimating Mean Response as a Function of Treatment Duration in an Observational Study, Where Duration May Be Informatively Censored
• Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials
• Evaluating the effect of early versus late ARV regimen change if failure on an initial regimen: results from the AIDS clinical trials group study A5095
• Marginal Mean Models for Dynamic Regimes
• Semiparametric inference in observational duration-response studies, with duration possibly right-censored
• Treatment-competing events in dynamic regimes

Cited in

(2)

• Estimating mean potential outcome under adaptive treatment length strategies in continuous time
• Evaluating the effect of early versus late ARV regimen change if failure on an initial regimen: results from the AIDS clinical trials group study A5095

This page was built for publication: Modeling clinical endpoints as a function of time of switch to second-line ART with incomplete data on switching times

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2861966)